Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Opler

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Clinical Psychopharmacology|December 24, 1998
Return of menstruation after switching from risperidone to olanzapineL R Gazzola, L A Opler
Psychiatric Developments|January 1, 1987
The positive-negative dimension in schizophrenia: its validity and significanceS R Kay, L A Opler
The Journal of Clinical Psychiatry|November 1, 1992
Akathisia, suicidality, and fluoxetineM S Hamilton, L A Opler
International Journal of Psychiatry in Medicine|January 1, 1985
L-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental studyS R Kay, L A Opler
The Journal of Clinical Psychiatry|May 1, 1991
The role of pimozide in clinical psychiatry: a reviewL A Opler, S S Feinberg
Biochemical and Biophysical Research Communications|February 16, 1972
Mediation by cyclic AMP of hormone-stimulated glycogenolysis in cultured rat astrocytoma cellsL A Opler, M H Makman
Comprehensive Psychiatry|January 1, 1994
Psychopharmacologic treatment of negative schizophrenic symptomsL A Opler, D Albert, P M Ramirez
Journal of Clinical Psychopharmacology|June 1, 1989
The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitorsD Kahn, J M Silver, L A Opler
The British Journal of Psychiatry : the Journal of Mental Science|October 1, 1986
Significance of positive and negative syndromes in chronic schizophreniaS R Kay, L A Opler, A Fiszbein
Schizophrenia Bulletin|January 1, 1987
The positive and negative syndrome scale (PANSS) for schizophreniaS R Kay, A Fiszbein, L A Opler
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Psychopharmacology|December 24, 1998
Return of menstruation after switching from risperidone to olanzapineL R Gazzola, L A Opler
Psychiatric Developments|January 1, 1987
The positive-negative dimension in schizophrenia: its validity and significanceS R Kay, L A Opler
The Journal of Clinical Psychiatry|November 1, 1992
Akathisia, suicidality, and fluoxetineM S Hamilton, L A Opler
International Journal of Psychiatry in Medicine|January 1, 1985
L-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental studyS R Kay, L A Opler
The Journal of Clinical Psychiatry|May 1, 1991
The role of pimozide in clinical psychiatry: a reviewL A Opler, S S Feinberg
Biochemical and Biophysical Research Communications|February 16, 1972
Mediation by cyclic AMP of hormone-stimulated glycogenolysis in cultured rat astrocytoma cellsL A Opler, M H Makman
Comprehensive Psychiatry|January 1, 1994
Psychopharmacologic treatment of negative schizophrenic symptomsL A Opler, D Albert, P M Ramirez
Journal of Clinical Psychopharmacology|June 1, 1989
The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitorsD Kahn, J M Silver, L A Opler
The British Journal of Psychiatry : the Journal of Mental Science|October 1, 1986
Significance of positive and negative syndromes in chronic schizophreniaS R Kay, L A Opler, A Fiszbein
Schizophrenia Bulletin|January 1, 1987
The positive and negative syndrome scale (PANSS) for schizophreniaS R Kay, A Fiszbein, L A Opler
Pageof 6